Biomarkers, Clinical Course, and Individual Needs in COPD Patients in Primary Care: The Study Protocol of the Stockholm COPD Inflammation Cohort (SCOPIC)

References

• Grahn K, Gustavsson P, Andersson T, et al. Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD): a population-based cohort study in Stockholm, Sweden. Environ Res. 2021;200:111739. doi:10.1016/j.envres.2021.111739
   PubMed Web of Science ®Google Scholar
• World Health Organization. Chronic obstructive pulmonary disease (COPD) [homepage on the Internet]; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-copd. Accessed January 11, 2022.
   Google Scholar
• Global initiative for chronic obstructive lung disease [homepage on the Internet]; 2022. Available from: http://www.goldcopd.com/. Accessed April 27, 2022.
   Google Scholar
• Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD?–Report from the obstructive lung disease in Northern Sweden studies. Respir Med. 2003;97(2):115–122. doi:10.1053/rmed.2003.1446
   PubMed Web of Science ®Google Scholar
• Backman H, Vanfleteren L, Lindberg A, et al. Decreased COPD prevalence in Sweden after decades of decrease in smoking. Respir Res. 2020;21(1):283. doi:10.1186/s12931-020-01536-4
   PubMed Web of Science ®Google Scholar
• Läkemedelsverkets riktlinjer för behandling av kroniskt obstruktiv lungsjukdom [The Swedish Medical Products Agency’s guidelines for treatment of chronic obstructive pulmonary disease] [homepage on the Internet]; 2015. Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/lakemedel-vid-kroniskt-obstruktiv-lungsjukdom-kol–behandlingsrekommendation. Accessed January 11, 2022. Swedish.
   Google Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• PRAXIS-studien astma KOL [The PRAXIS study of asthma and COPD] [homepage on the Internet]; 2022. Available from: http://www.praxisstudien.se/. Accessed January 11, 2022. Swedish.
   Google Scholar
• OLIN-studierna [The OLIN studies] [homepage on the Internet]; 2021. Available from: https://www.norrbotten.se/olin. Accessed January 11, 2022. Swedish.
   Google Scholar
• Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and Impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763–1774. doi:10.1007/s12325-018-0805-y
   PubMed Web of Science ®Google Scholar
• Fawcett J. The metaparadigm of nursing: present status and future refinements. Image J Nurs Sch. 1984;16(3):84–89. doi:10.1111/j.1547-5069.1984.tb01393.x
   PubMedGoogle Scholar
• Zwerink M, Brusse-Keizer M, van der Valk PD, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(3):CD002990. doi:10.1002/14651858.CD002990.pub3
   PubMed Web of Science ®Google Scholar
• Sjöstrand T, Sulaiman J. Living with COPD – Experiences from Daily Life. A Literature Review. [Degree Project in Nursing 15 Credit Points]. Accra: Malmö University; 2020.
   Google Scholar
• Lisspers K, Johansson G, Jansson C, et al. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study. Respir Med. 2014;108:1345–1354. doi:10.1016/j.rmed.2014.06.002
   PubMed Web of Science ®Google Scholar
• Sundström JWM Distriktssköterskans erfarenheter av kroniskt obstruktiv lungsjukdom i primärvården - en kvalitativ intervjustudie [District nurse’s experiences of chronic obstructive pulmonary disease in primary care: a qualitative interview study] [thesis]. Accra: Högskolan i Dalarna; 2020. Available from: http://www.diva-portal.org/smash/get/diva2:1390121/FULLTEXT01.pdf. Accessed January 11, 2022. Swedish.
   Google Scholar
• Lundh L, Hylander I, Tornkvist L. The process of trying to quit smoking from the perspective of patients with chronic obstructive pulmonary disease. Scand J Caring Sci. 2012;26(3):485–493. doi:10.1111/j.1471-6712.2011.00953.x
   PubMed Web of Science ®Google Scholar
• van Eerd EA, van Rossem CR, Spigt MG, Wesseling G, van Schayck OC, Kotz D. Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking. Respiration. 2015;90(3):211–219. doi:10.1159/000398816
   PubMed Web of Science ®Google Scholar
• Jones RC, Wang X, Harding S, Bott J, Hyland M. Educational impact of pulmonary rehabilitation: lung information needs questionnaire. Respir Med. 2008;102(10):1439–1445. doi:10.1016/j.rmed.2008.04.015
   PubMed Web of Science ®Google Scholar
• Sandelowsky H, Krakau I, Modin S, Stallberg B, Nager A. COPD patients need more information about self-management: a cross-sectional study in Swedish primary care. Scand J Prim Health Care. 2019;37(4):459–467. doi:10.1080/02813432.2019.1684015
   PubMed Web of Science ®Google Scholar
• Ansari S, Hosseinzadeh H, Dennis S, Zwar N. Patients’ perspectives on the impact of a new COPD diagnosis in the face of multimorbidity: a qualitative study. NPJ Prim Care Respir Med. 2014;24:14036. doi:10.1038/npjpcrm.2014.36
   PubMed Web of Science ®Google Scholar
• Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598–604. doi:10.1164/rccm.200912-1843CC
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Calle M, Molina J, et al. Spanish COPD Guidelines (GesEPOC) 2021: updated Pharmacological treatment of stable COPD. Arch Bronconeumol. 2021;58:T69–T81. doi:10.1016/j.arbres.2021.03.026
   PubMed Web of Science ®Google Scholar
• Calderon-Larranaga A, Vetrano DL, Onder G, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J Gerontol a Biol Sci Med Sci. 2017;72(10):1417–1423. doi:10.1093/gerona/glw233
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Tosca MA, Silvestri M, Ricciardolo FLM. Inflammatory biomarkers for asthma endotyping and consequent personalized therapy. Expert Rev Clin Immunol. 2017;13(7):715–721. doi:10.1080/1744666X.2017.1313117
   PubMed Web of Science ®Google Scholar
• Ho J, He W, Chan MTV, et al. Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis. Sci Rep. 2017;7(1):13451. doi:10.1038/s41598-017-13745-x
   PubMed Web of Science ®Google Scholar
• Andelid K, Andersson A, Yoshihara S, et al. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1253–1263. doi:10.2147/COPD.S77274
   PubMed Web of Science ®Google Scholar
• Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility. Lung. 2006;184(4):217–222. doi:10.1007/s00408-005-2586-8
   PubMed Web of Science ®Google Scholar
• D’Armiento JM, Scharf SM, Roth MD, et al. Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res. 2009;10:113. doi:10.1186/1465-9921-10-113
   PubMed Web of Science ®Google Scholar
• Andelid K, Tengvall S, Andersson A, et al. Systemic cytokine signaling via IL-17 in smokers with obstructive pulmonary disease: a link to bacterial colonization? Int J Chron Obstruct Pulmon Dis. 2015;10:689–702. doi:10.2147/COPD.S76273
   PubMed Web of Science ®Google Scholar
• Andersson A, Malmhall C, Houltz B, et al. Interleukin-16-producing NK cells and T-cells in the blood of tobacco smokers with and without COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2245–2258. doi:10.2147/COPD.S103758
   PubMed Web of Science ®Google Scholar
• Andersson A, Bossios A, Malmhall C, et al. Effects of tobacco smoke on IL-16 in CD8+ cells from human airways and blood: a key role for oxygen free radicals? Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L43–55. doi:10.1152/ajplung.00387.2009
   PubMed Web of Science ®Google Scholar
• Gadgil A, Duncan SR. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(4):531–541. doi:10.2147/COPD.S1759
   PubMedGoogle Scholar
• Williams M, Todd I, Fairclough LC. The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: a systematic review. Inflamm Res. 2021;70(1):11–18. doi:10.1007/s00011-020-01408-z
   PubMed Web of Science ®Google Scholar
• Forsslund H, Mikko M, Karimi R, et al. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Chest. 2014;145(4):711–722. doi:10.1378/chest.13-0873
   PubMed Web of Science ®Google Scholar
• Hodge G, Nairn J, Holmes M, Reynolds PN, Hodge S. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol. 2007;150(1):22–29. doi:10.1111/j.1365-2249.2007.03451.x
   PubMed Web of Science ®Google Scholar
• Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011;6:413–421. doi:10.2147/COPD.S10770
   PubMed Web of Science ®Google Scholar
• Padra M, Andersson A, Levanen B, et al. Increased MUC1 plus a larger quantity and complex size for MUC5AC in the peripheral airway lumen of long-term tobacco smokers. Clin Sci. 2020;134(10):1107–1125. doi:10.1042/CS20191085
   PubMed Web of Science ®Google Scholar
• Weldon S, McGarry N, Taggart CC, McElvaney NG. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem Soc Trans. 2007;35(Pt 2):273–276. doi:10.1042/BST0350273
   PubMed Web of Science ®Google Scholar
• Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy. 2000;30(4):469–475. doi:10.1046/j.1365-2222.2000.00760.x
   PubMed Web of Science ®Google Scholar
• Bernard A, Roels H, Buchet JP, Lauwerys R. Decrease of serum Clara cell protein in smokers. Lancet. 1992;339(8809):1620. doi:10.1016/0140-6736(92)91891-B
   PubMed Web of Science ®Google Scholar
• Rong B, Fu T, Gao W, et al. Reduced serum concentration of CC16 is associated with severity of chronic obstructive pulmonary disease and contributes to the diagnosis and assessment of the disease. Int J Chron Obstruct Pulmon Dis. 2020;15:461–470. doi:10.2147/COPD.S230323
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-3
   PubMed Web of Science ®Google Scholar
• Stockholms läns sjukvårdsområde bokslut 2018 [Stockholm County Council annual financial report 2018] [homepage on the Internet]; 2018. Available from: http://www.e-magin.se/paper/35ggrq8m/paper/1#/paper/35ggrq8m/42. Accessed January 11, 2022. Swedish.
   Google Scholar
• Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. doi:10.1111/j.1365-2648.2007.04569.x
   PubMed Web of Science ®Google Scholar